Product correctly added to cart.

discount label
Melittin, 70%
View 3D

Biosynth logo

Melittin, 70%

CAS: 20449-79-0

Ref. 3D-XM176021

1g
349.00 €
2g
466.00 €
5g
711.00 €
250mg
172.00 €
500mg
248.00 €
Estimated delivery in United States, on Friday 20 Dec 2024

Product Information

Name:
Melittin, 70%
Synonyms:
  • H-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2
  • Melittin From Bee Venom Sequencing*Grade
  • Beevenommelittin
Description:

Apitherapy (the use of honey bee products in alternative medicine) is an emerging field, with a long history of unsupported health benefits, particularly in cancer. Components of bee venom have been demonstrated to have antitumoral effects in various cancers. For example, honey bee venom (XM176021) was shown to reduce metastases of breast cancer to the lungs and inhibit tumour growth (Orsolić, et al., 2003). Similarly, the active component of bee venom, a peptide called melittin (FM10065), showed anticancer selectivity through undefined molecular mechanisms and suggests novel treatment strategies for aggressive breast cancers (Duffy, et al., 2020).

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
2,846.46 g/mol
Formula:
C131H229N39O31
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XM176021 Melittin, 70%

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".